Eugenol attenuates concanavalin A-induced hepatitis through modulation of cytokine levels and inhibition of mitochondrial oxidative stress
Keywords:hepatitis, ConA, eugenol, mitochondrial ROS, antioxidant
- The hepatoprotective effect of the phytochemical eugenol was examined.
- Concanavalin A (Con A) was used in Wistar albino rats to produce an experimental model of autoimmune hepatitis which mimics acute liver injury in humans. Eugenol, administered by oral gavage (5 mg/kg/day) for 5 days before and during Con A administration, exerted a hepatoprotective effect through modulation of lipid peroxidation, increased antioxidant enzyme activities, restoration of mitochondrial oxidative stress and cytokine levels (anti-inflammatory and anti-fibrogenic effects), as confirmed by histological findings.
- Eugenol can be considered as a potential hepatoprotective drug.
Abstract: Therapeutic management of hepatitis with conventional drugs alone worsens hepatic functioning in the long term because of sustained oxidative stress. Active compounds from several plant sources have been investigated to counteract this. Eugenol, a phytochemical abundant in various plants, is known for its wide range of pharmacological effects. There is a lacuna in the deeper understanding of its hepatoprotective activity at the molecular level. Our present study aimed to determine the effects of eugenol on the changes in antioxidant components, inflammatory cytokines and modulation of mitochondrial oxidative stress in immune-mediated hepatitis. We employed a model that mimics viral hepatitis using concanavalin A (ConA) to induce T-cell-mediated acute hepatitis. Eugenol increased (P<0.01) antioxidant enzyme activities, including reduced glutathione (GSH)-regenerating enzyme, glutathione reductase, and glucose-6-phosphate dehydrogenase. Its antiinflammatory and antifibrogenic effects were evident from the reduction (P<0.01) in interleukin and tumor necrosis factor levels. Eugenol was found to decrease mitochondrial oxidative stress, which was elevated in hepatitis. The hepatoprotective effects of eugenol were confirmed by histological findings. The current investigation shows that eugenol exerts a hepatoprotective effect through the modulation of different pathways which include restoration of mitochondrial oxidative stress. Eugenol could be a promising candidate for human hepatitis management, warranting preclinical studies.
Received: January 21, 2019; Revised: March 6, 2019; Accepted: March 11, 2019; Published online: March 20, 2019
How to cite this article: Liu J, Mao Y. Eugenol attenuates concanavalin A-induced hepatitis through modulation of cytokine levels and inhibition of mitochondrial oxidative stress. Arch Biol Sci. 2019;71(2):339-46.
Wang T, Dai Y, Lu W, Zhou H, Chen Y, Xu X, Sun C, Cheng J. An epidemiological survey of HBV infection and low-level HBsAg in military camps in eastern China. Medicine (Baltimore). 2018;97:e12201.
Qiu L, Tang Q, Li G, Chen K. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma. Life Sci. 2017;191:273-82.
Cao Q, Batey R, Pang G, Russell A, Clancy R. IL-6, IF-γ and TNF-α production by liver-associated T cells and acute liver injury in rats administered concanavalin A. Immunol Cell Biol. 1998;76:542-49.
Ruggieri A, Anticoli S, Nencioni L, Sgarbanti R, Garaci E, Palamara AT. Interplay between hepatitis C virus and redox cell signaling. Int J Mol Sci. 2013;14:4705-21.
Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Asp Med. 2000;21:49-98.
Paik Y-H, Kim J, Aoyama T, De Minicis S, Bataller R, Brenner DA. Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal 2014;20:2854-72.
Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992; 90:196-03.
Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 1995;21:190-98.
Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, Ogawa T, Kaneda K, Fujii T, Senoh H, Fujiwara H. Critical involvement of interferon gamma in the pathogenesis of T-cell activation associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology. 1996; 23:1608-15.
Nicoletti F, DiMarco R, Zaccone P, Salvaggio A, Magro G, Bendtzen K, Meroni P. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology. 2000;32:728-33.
Ballegeer M, Libert C. Different cell types involved in mediating concanavalin A induced liver injury: a comprehensive overview. J Gastroenterol Hepatology Res. 2016;1:1-7.
Shirin H, AeedH, Alin A, Matas Z, Kirchner M, Brazowski E, Goldiner I, Bruck R. Inhibition of immune-mediated concanavalin A induced liver damage by free-radical scavengers. Dig Dis Sci. 2010;55:268-75.
Hinnen C, Ranchor AV, Baas PC, Sanderman R, Hagedoorn M. Partner support and distress in women with breast cancer: The role of patients’ awareness of support and level of mastery. Psychol Health. 2009;24:439-55.
Jaganathan SK, Supriyanto E. Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells. Molecules. 2012;17:6290-04.
Ogata M, Hoshi M, Urano S, Endo T. Antioxidant activity of eugenol and related monomeric and dimeric compounds. Chem Pharm Bull (Tokyo). 2000;48:1467-69.
Pisano M, Pagnan G, Loi M, Mura ME, Tilocca MG, Palmieri G, Fabbri D, Dettori MA, Delogu G, Ponzoni M, Rozzo C. Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Mol Cancer. 2007;6:8-14.
Benencia F, Courreges M. C. In vitro and in vivo activity of eugenol on human herpesvirus. Phytother Res. 2000;14:495-500.
Rastogi SC, Johansen JD, Menne T. Natural ingredients based cosmetics. Content of selected fragrance sensitizers. Contact Dermatitis 1996;34:423-26.
Lairungruang K, Itharat A, Panthong S. Antimicrobial activity of extracts from a Thai traditional remedy called Kabpi for oral and throat infection and its plant components. J Med Assoc Thai. 2014; 97:S108-15.
RaviKumar S, Gnanadesigan N, Inbaneson SJ, Kalaiarasi A. Hepatoprotective and antioxidant properties of Suaeda maritima (L.) Dumort ethanolic extract on concanavalin A induced hepatotoxicity in rats. Indian J Exp Biol. 2011;49:455-60.
Xin HG, Zhang BB, Wu ZQ, Hang XF, Xu WS, Ni W, Zhang RQ, Miao XH. Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. Eur J Pharmacol. 2014;738:310-18.
Goyal H, Zhang GM. Serum biomarkers to predict liver fibrosis in hepatitis B. Clin Chim Acta. 2018;486:8-12.
Cachet X, Langrand J, Riffault-Valois L, Bouzidi C, Colas C, Dugay A, Michel S, Boucaud-Maitre D. Clerodane furanoditerpenoids as the probable cause of toxic hepatitis induced by Tinospora crispa. Sci Rep. 2018;8:13520.
Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget. 2017;8:3895-32.
Abd El Motteleb DM, Selim SA, Mohamed AM. Differential effects of eugenol against hepatic inflammation and overall damage induced by ischemia/re-perfusion injury. J Immunotoxicol. 2014;11:238-45.
Zhang C, Wang N, Xu Y, Tan HY, Li S, Feng Y. Molecular mechanisms involved in oxidative stress-associated liver injury induced by Chinese herbal medicine: An experimental evidence-based literature review and network pharmacology study. Int J Mol Sci. 2018;19(9):E2745.
Tadayuki I, Akiko T, Shinya S, Ken-ichi O, Ippei H, Yuko K, Koji T, Yoshimitsu M. A simple assay for measuring catalase activity: A visual approach. Sci Rep. 2013;3:3081.
Binu P, Priya N, Abhilash S, Vineetha RC, Nair H. Protective effects of eugenol against hepatotoxicity induced by arsenic trioxide: An antileukemic drug. Iran J Med Sci. 2018;43:305-12.
Binu P, Gifty K, Vineetha RC, Abhilash S, Arathi P, Nair RH. Eugenol, a plant-derived phenolic nutraceutical, protects thiol (SH) group in myocardium from ROS-mediated oxidation under chemotherapeutic stress induced by arsenic trioxide - a in vivo model study. Drug Chem Toxicol. 2018;4:352-57.
Binu P, Priya N, Abhilash S, Vineetha RC, Nair RH. Studies on curative efficacy of monoterpene eugenol on anti- leukemic drug arsenic trioxide induced cardiotoxicity. Biomed Pharmacother. 2017; 91:559-66.
Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal. 2007;19:1807-19.
Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G, Pagnan G, Loi M, Mura ME, Tilocca MG, Palmieri G, Fabbri D, Dettori MA, Delogu G, Ponzoni M, Rozzo C. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 1995;21:190-8.
Bruck R, Shirin H, Hershkoviz R, Lider O, Kenet G, Aeed H, Matas Z, Zaidel L, Halpem Z. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice. Gut. 1997;40:133-38.
Klein C, Wüstefeld T, Heinrich PC, Streetz KL, Manns MP, Trautwein C ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism. Eur J Immunol. 2003;33:2251-61.
Liang J, Zhang B, Shen RW, Liu JB, Gao MH, Li Y, Li YY, Zhang W. Preventive effect of halofuginone on concanavalin A induced liver fibrosis. PLoS One. 2013;8:82232.
Xia S, Han M, Li X, Cheng L, Qiang Y, Wu S, Zhang M, Xu H, Liu X, Shao Q. Dietary fish oil exacerbates concanavalin A induced hepatitis through promoting hepatocyte apoptosis and altering immune cell populations. J Toxicol Sci. 2014;39:179-90.
Yoshida K, Murata M, Yamaguchi T, Matsuzaki K. TGF-β/Smad signaling during hepatic fibro-carcinogenesis. Int J Oncol. 2014;45:1363-71.
Purohit V, Brenner DA. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology. 2006;43:872-8.
Kar MS, Bhattacharjee S, Chakraborty SP, Majumdar S, Roy S. Alteration of immune functions and Th1/Th2 cytokine balance in nicotine-induced murine macrophages: immunomodulatory role of eugenol and N-acetylcysteine. Int Immunopharmacol. 2011;11:485-95.
de Araújo Lopes A, da Fonseca FN, Rocha TM, de Freitas LB, Araújo EVO, Wong DVT, Lima Júnior RCP, Leal LKAM. Eugenol as a promising molecule for the treatment of dermatitis: antioxidant and anti-inflammatory activities and its nanoformulation. Oxid Med Cell Longev. 2018;2018:8194849.
Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155:629-47.
Alshammari GM, Balakrishnan A, Chinnasamy T. Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats. Biofactors. 2018;44:289-98.